Quick search
47 search result for "Tobacco"
08.05.2025
The CEIP-Framework – From Reaction to Prevention in Health in All and for Policies
This commentary highlights the critical role of Health in All Policies (HiAP), which is key to the complementary Health for All Policies strategy to enable positive outcomes across sectors and allow a broader policy integration. It discusses the impact of political determinants on the main public health risk factors related to tobacco, sugar, gambling and alcohol addressing the barriers hindering the implementation of HiAP in the example of Portugal. It highlights the need to funnel political determinants through a health equity framework to address inequalities. Inspired by the Portuguese experience, a CEIP-Framework is proposed to emphasize the need to strengthen HiAP, when a national agenda is absent. The CEIP-Framework considers comprehensive health legislation (C), enhanced reinforcement and monitoring (E), increased cross-sector collaboration (I), and public health investment (P) from Reaction to Prevention. In this commentary, the importance of strengthening HiAP by addressing four key public health challenges is discussed, by debating the impact of political determinants on health outcomes and proposing the CEIP-framework for fostering effective cross-sector collaboration in Portugal. Furthermore, this commentary gives insights related to barriers such as industry lobbying and cultural acceptance that hamper the effectiveness of health regulations targeting the key risk factors: tobacco, sugar, gambling, and alcohol and to propose a comprehensive framework for strengthening HiAP, emphasising the need for comprehensive health legislation, enhanced monitoring, increased cross-sector collaboration, and public health investment This work has been developed under the scope of WP9 Health in All Policies of the JA Prevent NCD which aims to strengthen the implementation of HiAP across various sectors and governance levels, focusing particularly on key risk factors and determinants to prevent cancer and other non-communicable diseases. Access the full commentary in The Public Health Reviews:Public Health Rev, 21 March 2025, Volume 46 - 2025 | DOI: 10.3389/phrs.2025.1608225
https://www.preventncd.eu/newsroom/news-updates/the-ceip-framework-from-reaction-to-prevention-in-health-in-all-and-for-policies/
07.05.2025
JA PreventNCD Participates in OECD Policy Dialogue on Cardiovascular Disease in the EU
On 5 May 2025, JA PreventNCD participated in the OECD Policy Dialogue on the Burden of Cardiovascular Disease (CVD) in the EU, held in Paris, France. The event was part of an ongoing effort to strengthen European and broader international approaches to preventing and managing CVD. Hosted by the Organisation for Economic Co-operation and Development (OECD), the meeting brought together a broad group of stakeholders, including representatives from governments across the EU and other OECD countries, as well as civil society organisations and intergovernmental bodies. The aim of the dialogue was to inform a forthcoming OECD report exploring how countries are addressing the burden of CVD — Europe’s leading cause of death — and what more can be done to improve both population-level and individual health outcomes. To ensure that stakeholder priorities are reflected in the report, several organisations and projects were invited to contribute, including JA PreventNCD and JACARDI. Both initiatives were asked to share their perspectives and priorities related to reducing the burden of CVD and improving health outcomes across Europe. As a joint action co-funded by the European Union with over 100 partner organisations in 25 countries, JA PreventNCD was pleased to provide insights on the prevention of CVD as part of its broader mission to reduce the burden of non-communicable diseases (NCDs). Linda Granlund, Project Coordinator of JA PreventNCD and Director of Public Health at the Norwegian Directorate of Health, presented the project’s current work and strategic approach. She underscored the importance of addressing shared risk factors, such as unhealthy diets, tobacco use, alcohol consumption, and physical inactivity, which contribute to both cardiovascular diseases and other NCDs. She also highlighted the critical role of policy-based and population-level approaches in reducing risk and improving health equity. JA PreventNCD welcomes the OECD’s focus on this topic and will continue to follow the development of the report, contributing relevant experiences and insights from our ongoing work whenever invited.
https://www.preventncd.eu/newsroom/news-updates/ja-preventncd-participates-in-oecd-policy-dialogue-on-cardiovascular-disease-in-the-eu/
26.03.2025
Quick Buys for Long-Term Gains: WHO Identifies 25 Fast-Acting Policies to Reduce the Burden of Non-Communicable Diseases
The global burden of noncommunicable diseases (NCDs) including cardiovascular diseases, cancer, diabetes, and chronic respiratory illnesses continues to rise, placing immense pressure on health systems, economies, and communities. In the WHO European Region, NCDs account for the vast majority of deaths and represent one of the biggest obstacles to achieving the Sustainable Development Goals (SDGs). For over a decade, the WHO has recommended a package of “best buys” evidence-based, cost-effective interventions to reduce exposure to the key NCD risk factors: tobacco and alcohol use, unhealthy diets, and physical inactivity. Yet, the implementation of these best buys has been slow and uneven across countries, and progress toward global targets remains off track. To bridge the gap between policy and action, a new publication from WHO/Europe introduces the concept of “Quick Buys” a refined set of interventions that deliver measurable population health impacts within five years, aligning with typical political and electoral cycles. “Policymakers often face short time horizons. This can be a barrier to adopting NCD policies that are perceived to take too long to show results. The Quick Buys address that by identifying interventions that are not only effective and affordable but also fast-acting.”— Dr. Kremlin Wickramasinghe, WHO Europe What Are Quick Buys? Selected based on strong evidence and their ability to show results within five years, these interventions focus on reducing exposure to risk factors and improving treatment outcomes. Here are some key examples: Tobacco & Alcohol Control Smoke-free laws and increased tobacco taxes have immediate effects on health outcomes. Alcohol tax increases and advertising bans reduce total consumption quickly. Healthier Diets Front-of-pack nutrition labels help consumers make better choices immediately. Mass media campaigns promoting healthy eating show effects within 3 years. Chronic Disease Treatment Hypertension treatment can lower cardiovascular risk within 10 days. Early diabetes control and statin use reduce mortality and complications rapidly. Cancer Prevention HPV vaccination for girls and early cervical cancer screening have immediate population-level impact. JA PreventNCD Supports Swift Action on NCDs As the 2030 deadline for the SDGs approaches, including Target 3.4 (reducing premature NCD mortality by one-third), countries must accelerate implementation. Yet policymakers are frequently constrained by political realities: budgets, lobbying pressures, and election cycles. The WHO Quick Buys aim to shift the conversation: away from long-term, abstract benefits toward concrete, near-term health gains. These interventions show that real progress is possible within a single electoral term, offering a politically feasible pathway to meet global health targets. “These Quick Buys show that investing in prevention doesn’t have to mean waiting decades to see results. With the right political will and intersectoral collaboration, countries can deliver real, measurable health benefits within five years—and JA PreventNCD is working to make that happen,”- Knut-Inge Klepp, Scientific Coordinator, JA PreventNCD. For countries participating in the JA PreventNCD, the Quick Buys offer a credible set of policy options to prioritize based on evidence and impact. They also provide a practical pathway to demonstrate early success showing measurable health improvements within a few years while continuing to build momentum for broader, long-term reforms. The JA PreventNCD was represented by Hanna Tolonen, leader of the Health in All Policies work in JA PreventNCD at the event. She highlighted the critical role of monitoring systems in ensuring the effectiveness and equity of public health interventions, allowing us to track progress and make informed decisions about where to focus future efforts. In public health, time matters The new Quick Buys framework doesn’t replace the need for long-term investment, but it shows that smart policy decisions can have swift, measurable, and lasting effects. For countries seeking to meet their commitments under the SDGs and reduce the burden of NCDs, these 25 interventions offer a clear place to start today. Access the full study in The Lancet Regional Health – Europe:Quick Buys for Prevention and Control of Noncommunicable Diseases, March 2025DOI: 10.1016/j.lanepe.2025.101281
https://www.preventncd.eu/newsroom/news-updates/quick-buys-for-long-term-gains-who-identifies-25-fast-acting-policies-to-reduce-the-burden-of-non-communicable-diseases/
17.03.2025
JA PreventNCD Welcomes the Launch of the MEP Interest Group
Non-communicable diseases (NCDs) remain one of the greatest public health challenges in Europe. It causes 80% of deaths in the EU and take up to 10% of the GDP spent on healthcare, yet only 3% of health budgets go to prevention, even though prevention could reduce the burden by up to 70%. In February, the Members of the European Parliament (MEP) Interest Group on Health Inequalities, Prevention and Risk Factors was launched. This marks a significant step forward in addressing the NCD challenges and advancing evidence-based policy measures to tackle the disease burden. The event was well attended by MEPs, representatives from Member States, the World Health Organization (WHO), and civil society. JA PreventNCD was represented by leader of Work Package on Regulation and Taxation, Arnfinn Helleve from the Norwegian Institute of Public Health (NIPH) and co-leader of Work Package on Sustainability, Gabrielle Schittecatte from Sciencano, Belgium. The interest group is led by a dedicated team of MEP Co-Chairs: • Vytenis Andriukaitis (S&D) • Manuela Ripa (EPP) • Vlad Voiculescu (Renew) • Ignazio Marino (Greens/EFA) • Aurelijus Veryga (ECR) • Ondřej Dostál (Non-attached) The JA PreventNCD project recognizes the critical role of political commitment in driving policy change. As Arnfinn Helleve, emphasizes: "Engaging with policy decision-makers at both the EU and Member State levels is essential for the success of the JA PreventNCD project. The newly established MEP interest group will be a key ally in our efforts. We hope to serve as a bridge between parliamentary groups and Member States to drive impactful policy change in NCD prevention." This initiative arrives at a crucial time when many public health policies face strong opposition from well-organized commercial interest groups. Industries with vested interests often lobby against regulatory measures designed to reduce alcohol and tobacco consumption, improve nutrition, and promote healthier lifestyles. Helleve underscores this concern: "There are many strong interest groups actively lobbying against policy initiatives aimed at preventing NCDs. Initiatives like the new MEP Interest Group are crucial to ensuring that public health policy discussions are protected from interference from commercial interests."
https://www.preventncd.eu/newsroom/news-updates/ja-preventncd-welcomes-the-launch-of-the-mep-interest-group/
07.03.2025
Advancing NCD Prevention: Key Takeaways from the Budapest ExCo Meeting
The first in-person meeting of the JA PreventNCD Executive Committee (ExCo) External Advisory Board (EEAB) meetings of 2025 were held on March 5-6, at the National Center for Public Health and Pharmacy (NNGYK) in Budapest, Hungary. These meetings are milestones for the project, bringing together work package (WP) leaders, the EEAB members and the project’s coordinators of cross-cutting themes, nutrition, physical activity, alcohol and tobacco to discuss progress, challenges and the way forward. Day 1: Strategic Discussions and Project Outcomes The meeting began with a warm welcome from Dr. Orsolya Surján, Deputy Chief Medical Officer at NNGYK, alongside Dr. Krisztina Biró Ministry of Interior, Department for Health Policy and JA PreventNCD coordinators Prof. Knut-Inge Klepp and Dr. Linda Granlund. The morning sessions focused on sustainability and best practices, with expert insights from the European Commission, WHO, and OECD on leveraging EU Best Practice Portals and WHO Best Buys for effective NCD prevention strategies. Presentations from Dr. Gauden Galea and Dr. Marion Devaux emphasized the importance of policy-driven, evidence-based approaches to public health challenges. Throughout the day, discussions covered key project outcomes and expected 2025 outputs, with leaders working on regulation and taxation, health in all policies, identifying individuals at risk, social inequalities, healthy living environments monitoring. Additionally, the participants discussed sustainability and long-term strategies for maintaining project impact beyond the Joint Action’s duration. Day 2: Evaluation, Communication, and Future Strategies Day two focused on project evaluation, covering key outcomes, methodologies, and plans for selecting implementation case studies. Later in the morning, updates on communication strategies, stakeholder mapping, and private sector involvement were shared, followed by a surprise segment and a group photo. The afternoon featured parallel meetings, with the ExCo addressing reporting, thematic coordination, and risk monitoring, while the EEAB held its own discussions. The meeting concluded with feedback from EEAB members, final reflections, and a discussion on the next steps for JA PreventNCD presented by the Chair of the Board Prof. Harry Rutter. Looking Ahead The Budapest ExCo and EEAB meetings reinforced the project’s commitment to advancing NCD prevention in Europe. With a strong foundation in place, discussions focused on how to move forward, improve strategies, and maximize impact. Work packages addressed previous feedback, fostering valuable reflections from the EEAB. Participants emphasized the importance of breaking silos, creating synergies, and aligning efforts across the initiative. As one of the largest EU4Health Joint Actions to date, JA PreventNCD aims to demonstrate meaningful impact by fostering collaboration, promoting high scientific quality, and ensuring coherence in objectives. The meeting served as a platform to evaluate progress, identify challenges, and explore solutions, laying the groundwork for the next phase of the project.
https://www.preventncd.eu/newsroom/news-updates/advancing-ncd-prevention-key-takeaways-from-the-budapest-exco-meeting/
06.02.2025
Together for Europe’s Health – strategic orientations and actions for public health
Poland assumed the presidency of the Council of the European Union on January 1, 2025, marking the start of a crucial six-month period where it will play a leading role in shaping the EU agenda. As part of its presidency, the Ministry of Health of Poland hosted the conference Together for Europe’s Health – strategic orientations and actions for public health, on January 16 in Warsaw. The conference provided an opportunity to explore innovative solutions, share best practices, foster international collaboration in healthcare, and discuss key challenges and opportunities in promoting health, preventing diseases, addressing the mental health needs of children and young people, and advancing the digital transformation of healthcare systems. This aligns closely with the objectives of JA PreventNCD, which supports EU Member States in strengthening policies to prevent non-communicable diseases (NCDs) through evidence-based approaches.
https://www.preventncd.eu/newsroom/news-updates/together-for-europe-s-health-strategic-orientations-and-actions-for-public-health/
04.02.2025
The right place at the right time – JACARDI is seizing the moment in EU Public Health Policy
The JACARDI consortium begins the new year with renewed energy and optimism, strengthened by significant public health announcements made in Brussels at the close of 2024. These developments validate JACARDI’s mission and reassure the experts involved that its Joint Action and pilot projects in 19 European countries are well-aligned with the priorities of the European Union. Notable milestones include the EU Commission's endorsement of the Cardiovascular Health Plan, the newly appointed Commissioner for Health and Animal Safety’s strong focus on cardiovascular prevention and treatment, the Aerosol-Free Initiative, the European Parliament’s decision to create a standing committee on public health, and Poland’s commitment to prioritizing public health during its Presidency. Together, these advancements demonstrate that momentum is building for better prevention and treatment of non-communicable diseases (NCDs).
https://www.preventncd.eu/newsroom/partnerships-collaborations/the-right-place-at-the-right-time-jacardi-is-seizing-the-moment-in-eu-public-health-policy/